Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-stage Small Cell Lung Cancer (LS-SCLC)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06914050
What this trial is testing

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Who this might be right for
Lung Cancer, Small CellLimited-stage Small Cell Lung Cancer (LS-SCLC)
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07008716
What this trial is testing

Omitting CTV for Primary Tumor in LS-SCLC

Who this might be right for
SCLC, Limited StageRadiation ExposureRadiotherapy Side Effect+1 more
Sun Yat-sen University 852
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Testing effectiveness (Phase 2)Looking for participantsNCT07055581
What this trial is testing

Durvalumab as Consolidation for Patients LS-SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Qian Chu 100
Testing effectiveness (Phase 2)UnknownNCT05483543
What this trial is testing

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 44
Not applicableStudy completedNCT07050472
What this trial is testing

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Who this might be right for
Small-cell Lung Cancer
Anhui Shi, MD 45
Testing effectiveness (Phase 2)Looking for participantsNCT06943235
What this trial is testing

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 60
Testing effectiveness (Phase 2)UnknownNCT02738723
What this trial is testing

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03811002
What this trial is testing

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Lung Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 544
Not applicableLooking for participantsNCT06869239
What this trial is testing

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07357532
What this trial is testing

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

Who this might be right for
Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute 44
Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773156
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Second Affiliated Hospital of Nanchang University 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05904015
What this trial is testing

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Looking for participantsNCT06773910
What this trial is testing

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Who this might be right for
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC 250
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Large-scale testing (Phase 3)UnknownNCT02990780
What this trial is testing

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

Who this might be right for
SCLC
Shanghai Chest Hospital 266
Large-scale testing (Phase 3)Looking for participantsNCT06117774
What this trial is testing

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
Amgen 400
Load More Results